GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jamjoom Pharmaceuticals Factory Co (SAU:4015) » Definitions » EPS (Diluted)

Jamjoom Pharmaceuticals Factory Co (SAU:4015) EPS (Diluted) : ﷼5.09 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jamjoom Pharmaceuticals Factory Co EPS (Diluted)?

Jamjoom Pharmaceuticals Factory Co's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was ﷼0.73. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ﷼5.09.

Jamjoom Pharmaceuticals Factory Co's EPS (Basic) for the three months ended in Dec. 2024 was ﷼0.73. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was ﷼5.09.

Jamjoom Pharmaceuticals Factory Co's EPS without NRI for the three months ended in Dec. 2024 was ﷼0.85. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was ﷼5.39.

During the past 12 months, Jamjoom Pharmaceuticals Factory Co's average EPS without NRIGrowth Rate was 27.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 29.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Jamjoom Pharmaceuticals Factory Co's highest 3-Year average EPS without NRI Growth Rate was 29.30% per year. The lowest was 10.80% per year. And the median was 20.05% per year.


Jamjoom Pharmaceuticals Factory Co EPS (Diluted) Historical Data

The historical data trend for Jamjoom Pharmaceuticals Factory Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jamjoom Pharmaceuticals Factory Co EPS (Diluted) Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Diluted)
2.96 2.44 2.45 4.18 5.09

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 1.47 1.53 1.36 0.73

Competitive Comparison of Jamjoom Pharmaceuticals Factory Co's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Jamjoom Pharmaceuticals Factory Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jamjoom Pharmaceuticals Factory Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jamjoom Pharmaceuticals Factory Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Jamjoom Pharmaceuticals Factory Co's PE Ratio falls into.


;
;

Jamjoom Pharmaceuticals Factory Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Jamjoom Pharmaceuticals Factory Co's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(356.524-0)/70.000
=5.09

Jamjoom Pharmaceuticals Factory Co's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(51.608-0)/70.000
=0.74

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼5.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jamjoom Pharmaceuticals Factory Co  (SAU:4015) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Jamjoom Pharmaceuticals Factory Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Jamjoom Pharmaceuticals Factory Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Jamjoom Pharmaceuticals Factory Co Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box No. 6267, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.

Jamjoom Pharmaceuticals Factory Co Headlines

No Headlines